21-06-2011. Lors du «Capital Markets Day 2011», qui se déroulera au Centre de Recherche Jealott’s Hill de Syngenta, au R.-U., l’équipe dirigeante mettra en évidence le potentiel de croissance considérable que recèle la nouvelle stratégie intégrée de l’entreprise. Ils expliqueront comment Syngenta ambitionne d’augmenter ses parts de marché, en s'appuyant sur une organisation commerciale et R&D entièrement intégrée et une approche mondiale orientée cultures. La journée sera l’occasion aussi d’insister sur l’ampleur des technologies à disposition de l’entreprise pour toutes les principales cultures mondiales: céréales, maïs, oléagineux, riz, soja, canne à sucre et potagères.

«Depuis l’annonce de notre nouvelle stratégie, en février, nous avons considérablement progressé dans sa mise en oeuvre. Aujourd’hui, nous partageons le potentiel de création de valeur de cette stratégie», a déclaré Mike Mack, Chief Executive Officer. «Syngenta se concentre sur la découverte et le développement de solutions intégrées qui vont au-delà d’une approche mono-produit. Notre confiance dans le potentiel de croissance futur de notre activité repose sur un pipeline d’innovations qui permettra de faire passer le chiffre d’affaires de 8,4 à 17 milliards $ sur les principales cultures, après 2015. Si l’on y ajoute notre modèle d’entreprise intégré, nous avons toutes les cartes en main pour réaliser une croissance supérieure à celle du marché mondial et offrir des rendements supérieurs aux attentes de nos actionnaires. Par ailleurs, la bonne tenue de notre chiffre d’affaires au cours du second trimestre, en dépit de conditions météo peu favorables, prouve la solidité de notre portefeuille actuel, autour duquel s’articule notre nouvelle stratégie.»  «Syngenta entre aujourd’hui dans une ère plus passionnante que jamais, placée sous le signe de l’innovation et de la productivité», a déclaré Sandro Aruffo, Directeur mondial de la Recherche & Développement de Syngenta. «Notre approche de la recherche et du développement, orientée cultures et producteurs, associée à l’ampleur des technologies à disposition et à la qualité de nos scientifiques, nous conforte dans la conviction que nous continuerons à réaliser des performances supérieures à la moyenne dans les années qui viennent.»

Syngenta figure parmi les leaders mondiaux pour ses activités. Le groupe emploie plus de 26 000 personnes dans plus de 90 pays qui n’ont qu’un seul objectif: exprimer le potentiel des plantes. Par nos capacités scientifiques de premier plan, notre présence mondiale et notre engagement en faveur des clients, nous aidons à accroître les rendements et la rentabilité des cultures, à protéger l’environnement et à améliorer la santé et la qualité de vie.

__________________

Disclaimer: You agree that  B2Bioworld is not responsible and will not be held liable for any third party content on its sites or any third-party content, products or services available on other web sites accessed through links from B2Bioworld sites. Links to third-party sites are for your convenience only, and their inclusion on   B2Bioworld's sites does not imply any endorsement, guarantee, warranty or representation by  B2Bioworld.

December 14, 2010. Syngenta and DuPont today announced that Syngenta will grant DuPont business, Pioneer Hi-Bred, a non-exclusive, global license to its corn rootworm trait MIR604 (Agrisure®) for corn seed. The trait provides protection from below-ground coleopteran insects, including corn rootworm, a major corn pest in the United States and around the world.
The license, which takes effect on 1 January 2011, gives Pioneer full stacking rights of MIR604 with other traits. The value of the deal could exceed $400 million in cumulative payments. Detailed financial terms were not disclosed.
Davor Pisk, Chief Operating Officer, Syngenta Seeds said: “This agreement is a further affirmation of Syngenta’s biotechnology capability. The creation of value through trait outlicensing, as well as through the incorporation of leading proprietary technology in our own branded offer, will contribute to the growing profitability of our Seeds business.”
“This rootworm trait provides Pioneer with additional product options for our customers continuing our momentum in the marketplace,” said Paul E. Schickler, Pioneer President. “Pioneer is creating unique trait combinations to offer next generation insect protection products. The new products will deliver growers additional choice in the Optimum® AcreMax™ family of products.”
Source: Syngenta

____________________________________________________________________________

Disclaimer: You agree that B2Bioworld is not responsible and will not be held liable for any third party content on its sites or any third-party content, products or services available on other web sites accessed through links from B2Bioworld sites. Links to third-party sites are for your convenience only, and their inclusion on B2Bioworld's sites does not imply any endorsement, guarantee, warranty or representation by B2Bioworld.

November 2009. A large international team of researchers recently published the 240-megabase DNA sequence of Phytophthora infestans, a robust parasitic water mold responsible for the Irish potato famine of the 1840s, in Nature (1). Breeders have not been able to produce potato cultivars that remain resistant to this insidious blight, aptly named as the plant (phyto) destroyer (phthora). This fungal-like pathogen is an oomycete, an eukaryote related to algae and diatoms that is transferred by wind-borne spores that spread rapidly and germinate on wet leaves, killing entire fields of potatoes, tomatoes, and other plants within a few weeks. Conservative estimates of potato crop losses attributed to late blight are about 16% (US$ 7.7 billion) of the global potato crop (US$ 47.2 billion) each year (2). The sequencing of this mold and subsequent genomic analyses will now help reveal details of its biologic and pathogenic processes, allowing more rapid development of reliable, environmentally benign, and economically feasible management tactics as well as insight into new breeding strategies.
Yearly potato production (300 Mt) substantially contributes to worldwide food security, surpassed only by wheat (630 Mt) and rice (608 Mt)(2). While it is important to identify the problem genes responsible for infection, it is equally important to identify the genes that develop resistance.
Brian J. Haas, a primary contributor from the Broad Institute of MIT and Harvard, noted that “NimbleGen services generated the data that made it possible for us to identify key genes in pathogenesis, as described in our recent Nature publication on the potato blight genome. In particular we identified a large number of so-called effector genes that are critical to pathogenesis that had been previously unknown and are extremely challenging to predict because of their small size and unusual structure.”
Senior author Chad Nusbaum, co-director of the Broad Institute’s Genome Sequencing and Analysis Program, added that “NimbleGen services generated data that made it possible for us to identify these genes in a timely and cost-competitive manner.”
The authors capitalized on Roche NimbleGen’s flexible array design capability to use the data from the newly sequenced genome to build a custom gene expression microarray, which helped measure gene level changes between the vegetative stage and infection stage. Nearly 3% of approximately 18,000 genes analyzed on the NimbleGen Gene Expression microarray are induced at least twofold during infection. Some of the induced genes belong to gene families with functions previously known to be involved in infection, such as RXLR genes, which may maintain virulence by suppressing host cell death. Understanding the P. infestans genes responsible for potato blight, and having unraveled its genetic code, will lead to methods for controlling the infection to improve food production and reduce the impact on worldwide crop losses.

(1) BJ Haas, S Kamoun, et al., Nature 2009 September 17; 241: 393–398; doi: 10.1038/nature08358
(2) AJ Haverkort, PC Struik, et al., Potato Res 2009 August 8; 52:249-264; doi: 10.1007/s11540-009-9136-3

______________________________________________________________________________________________

--> Disclaimer: You agree that B2Bioworld is not responsible and will not be held liable for any third party content on its sites or any third-party content, products or services available on other web sites accessed through links from B2Bioworld sites. Links to third-party sites are for your convenience only, and their inclusion on B2Bioworld's sites does not imply any endorsement, guarantee, warranty or representation by B2Bioworld.